Wells Fargo
PRAX icon

Wells Fargo’s Praxis Precision Medicines PRAX Stock Holding History

Wells Fargo’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.34M Buy
27,889
+16,275
+140% +$5.15M ﹤0.01% 2245
2026
Q1 		$3.74M Sell
11,614
-13,621
-54% -$4.21M ﹤0.01% 2827
2025
Q4 		$7.44M Buy
25,235
+11,630
+85% +$2.17M ﹤0.01% 2303
2025
Q3 		$721K Buy
13,605
+2,353
+21% +$114K ﹤0.01% 4044
2025
Q2 		$473K Buy
11,252
+2,735
+32% +$104K ﹤0.01% 4190
2025
Q1 		$323K Sell
8,517
-95
-1% -$5.93K ﹤0.01% 4380
2024
Q4 		$663K Buy
8,612
+2,746
+47% +$199K ﹤0.01% 3993
2024
Q3 		$338K Sell
5,866
-211
-3% -$11.4K ﹤0.01% 4249
2024
Q2 		$251K Buy
6,077
+5,423
+829% +$256K ﹤0.01% 4357
2024
Q1 		$39.9K Buy
654
+587
+876% +$26.3K ﹤0.01% 5346
2023
Q4 		$1.49K Buy
67
+4
+6% +$72 ﹤0.01% 6144
2023
Q3 		$1.6K Buy
63
+39
+163% +$738 ﹤0.01% 6126
2023
Q2 		$416 Sell
24
-543
-96% -$8.31K ﹤0.01% 6528
2023
Q1 		$6.88K Buy
+567
New +$23.9K ﹤0.01% 5968
2022
Q4 		– Sell
-10
Closed – – 7653
2022
Q3 		$0 Sell
10
-187
-95% -$9.32K ﹤0.01% 7197
2022
Q2 		$7K Sell
197
-1
-0.5% -$107 ﹤0.01% 5899
2022
Q1 		$31K Sell
198
-875
-82% -$180K ﹤0.01% 5856
2021
Q4 		$318K Buy
1,073
+971
+952% +$285K ﹤0.01% 5008
2021
Q3 		$28K Buy
102
+90
+750% +$24.4K ﹤0.01% 5856
2021
Q2 		$3K Sell
12
-109
-90% -$39K ﹤0.01% 6477
2021
Q1 		$59K Sell
121
-261
-68% -$186K ﹤0.01% 5741
2020
Q4 		$315K Buy
+382
New +$223K ﹤0.01% 4852

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Wells Fargo's PRAX Position: Q2 2026 in Review

Wells Fargo increased its Praxis Precision Medicines (PRAX) stake by 140% in Q2 2026, buying an estimated $5.15M and bringing the position to 27,889 shares worth $9.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

Wells Fargo first reported a position in PRAX in Q4 2020 and has held it in 22 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Wells Fargo held 27,889 shares of Praxis Precision Medicines worth $9.34M as of Q2 2026.
  • Wells Fargo bought 16,275 Praxis Precision Medicines shares in Q2 2026, an estimated $5.15M.
  • Praxis Precision Medicines made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #2245 holding.
  • Wells Fargo first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 22 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.